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including splicing factors and hnRNP proteins and are
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1 Laboratory of Molecular Neuro-Oncology domains (Kiledjian and Dreyfuss, 1992; Steinert et al.,
1991). While the function of the RGG motif is unclear,The Rockefeller University
New York, New York 10021 one hypothesis has been that it increases RNA binding
affinity in a non-sequence-specific manner by disrupting2 Howard Hughes Medical Institute
Departments of Human Genetics, Biochemistry, RNA secondary structure, thereby allowing access to
specific sequences by other RNA binding domains (Ghi-and Pediatrics
Emory University School of Medicine solfi et al., 1992a, 1992b; Kiledjian and Dreyfuss, 1992).
Although sequence-specific RNA-protein interactionsAtlanta, Georgia 30322
have been defined for several KH-type RNA binding
proteins including the neuronal paraneoplastic disease
antigen Nova (Buckanovich and Darnell, 1997; JensenSummary
et al., 2000b), the splicing factor SF1/BBP (Berglund et
al., 1998), and hnRNPs K and E1/E2 (Ostareck et al.,Loss of fragile X mental retardation protein (FMRP)
function causes the fragile X mental retardation syn- 1997; Thisted et al., 2001), the RNA specificity with which
FMRP binds RNA has remained unexplored. This ques-drome. FMRP harbors three RNA binding domains,
associates with polysomes, and is thought to regulate tion is of particular interest to the fragile X syndrome,
since one severely affected individual harbors a singlemRNA translation and/or localization, but the RNAs
to which it binds are unknown. We have used RNA amino acid change (I304N) within the second KH domain
of FMRP (DeBoulle et al., 1993). Some of the conse-selection to demonstrate that the FMRP RGG box
binds intramolecular G quartets. This data allowed us quences of this mutation on FMRP, such as its inability
to form a homodimer (Absher et al., 2001; Laggerbauerto identify mRNAs encoding proteins involved in syn-
aptic or developmental neurobiology that harbor et al., 2001), failure of the mutant protein to interact with
polyribosomes (Absher et al., 2001; Feng et al., 1997a),FMRP binding elements. The majority of these mRNAs
have an altered polysome association in fragile X pa- and more rapid protein shuttling between the nucleocy-
toplasmic space (Tamanini et al., 1999), have beentient cells. These data demonstrate that G quartets
serve as physiologically relevant targets for FMRP and noted. Cocrystallization of the Nova KH3 domain with
its RNA target predicts that the mutated isoleucine inidentify mRNAs whose dysregulation may underlie hu-
man mental retardation. FMRP (I304N) lies at the core of the hydrophobic RNA
binding pocket of the KH domain (Lewis et al., 2000).
These observations suggest that identification of theIntroduction
RNA targets to which FMRP binds will yield biologically
important insight into its function.The fragile X syndrome is the most common form of
inherited mental retardation, manifested by mild to mod- The role of FMRP as an RNA binding protein has
been most clearly established by the demonstration thaterate cognitive and behavioral abnormalities accompa-
nied by macroorchidism and subtle craniofacial dysmor- 85% of cellular FMRP is present on actively translating
polyribosomes (Feng et al., 1997a). Interestingly, thephia. The syndrome usually results from the expansion
and hypermethylation of a CGG repeat in the 5 UTR of I304N mutant FMRP is not found in the polysome frac-
tions (Feng et al., 1997a), consistent with an importantthe FMR1 gene that results in transcriptional silencing
(reviewed by Jin and Warren, 2000), indicating that the role for the protein in regulating mRNA translation.
Within the brain, FMRP is highly concentrated in neuronspresence of FMRP is essential for higher cognitive
function. with little or no expression in glia (Abitbol et al., 1993;
Cloning the FMR1 gene led to the finding that FMRP Devys et al., 1993; Hinds et al., 1993). At a subcellular
is an RNA binding protein (Ashley et al., 1993; Siomi et level, FMRP localizes to the perikaryon and dendrites
al., 1993b). FMRP contains two tandem RNA binding in a pattern consistent with the location of neuronal
KH domains and a C-terminal RGG box. KH domains polysomes (Feng et al., 1997b). It has both a nuclear
were first described in hnRNP K (Siomi et al., 1993a) localization signal and a Rev-like export signal and is
and subsequently were found to be present in a number believed to shuttle in and out of the nucleus (Eberhart
of RNA binding proteins of diverse function, including et al., 1996; Feng et al., 1997b; Fridell et al., 1996; Sittler
RNA localization (zip code binding protein), translational et al., 1996). The most profound finding on autopsy in
control (hnRNP K and hnRNPE1/E2), pre-mRNA splicing FMRP patients is the presence of very long and thin
(Nova-1, MER-1, SF1, KSRP, and PSI), shuttling tran- dendritic spines in the neocortex (Hinton et al., 1991;
scripts to the cytoplasm (hnRNP K), and regulation of Rudelli et al., 1985), and similar dendritic spine abnor-
mRNA stability (hnRNP E1/E2) (reviewed by Burd and malities are present in Fmr1 null mice (Comery et al.,
Dreyfuss, 1994; Lewis et al., 2000). RGG boxes are found 1997; Nimchinsky et al., 2001). One unifying model for
FMRP function is that it shuttles mRNAs from the nu-
cleus to postsynaptic sites where mRNAs are held in a3 Correspondence: darnelr@rockvax.rockefeller.edu
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Figure 1. Purified FMRP Selected a Popula-
tion of RNAs Containing the Consensus
(DWGG)4
(A) Purified baculoviral FMRP was run on
8% SDS-PAGE, transferred to nitrocellulose,
and visualized by colloidal gold staining (CG)
followed by Western blotting (WB) with
mAb2160 (Chemicon). An arrow marks the
position of FMRP, and dots mark the location
of contaminants in the loading buffer (data
not shown).
(B) Sequences of the 52 bp random region
(corresponding to bp 21–72 of sc1, see Ex-
perimental Procedures) of the six winning se-
quences from RNA selection rounds 8 and 9,
designated sc1–sc6. sc1 and sc2 each com-
prised 37.5% of round 9 clones. Conserved
motifs are shown in bold.
(C) Conserved sequences of the RNA selec-
tion are shown aligned with their consensus.
Kds were determined by filter binding assay.
D is any nucleotide except C, W is U or A,
and N is any nucleotide.
translationally inactive form until synaptic input alters FMRP shifted the migration of sc1 RNA to a more slowly
migrating band (Figure 2B, long arrow). An irrelevantFMRP activity to allow mRNA translation.
We have used in vitro RNA selection to determine that KH-type RNA binding protein, Nova, did not shift sc1
RNA, and FMRP did not shift the migration of an irrele-RNA ligands which form intramolecular G quartets are
recognized by the FMRP RGG box. Using this data, we vant RNA. Addition of a monoclonal antibody to FMRP
supershifted sc1 migration (Figure 2B, arrowhead), whileidentify a set of mRNAs that bind with high affinity to
FMRP, including mRNAs that interact with FMRP via an an irrelevant monoclonal did not. Taken together, these
data demonstrate a direct and specific interaction be-independent co-IP strategy and that are altered in their
polysome distribution in FMRP null cells. At least ten tween FMRP and sc1 RNA.
To determine the minimal RNA sequence necessaryof thirteen candidate mRNA targets encode proteins
involved in synaptic or developmental neuronal biology, for high-affinity FMRP binding, we examined the interac-
tion with a minimal RNA corresponding to the sc1 con-suggesting that our approach may lead directly to the
identification of mRNAs whose metabolism is altered in served element (bold in Figure 1B), but we were unable
to detect any binding (data not shown). This suggestedmental retardation.
that additional sequences outside the conserved ele-
ment were essential for binding and led us to map theResults
5 and 3 boundaries of the RNA that interacted with
FMRP. Full-length sc1 RNA was end-labeled with 32PIn Vitro RNA Selection with FMRP
and subjected to mild alkaline hydrolysis to generate aBaculoviral histidine-tagged FMRP was purified by se-
ladder of 3- or 5-labeled RNAs (Figure 3A). These RNAsquential metal-chelating and polyribo-G affinity chro-
were bound to FMRP, filtered through nitrocellulose tomatographies (Figure 1A). This FMRP was bound to a
capture FMRP-RNA complexes, eluted, and analyzednickel-Sepharose column and used to bind a pool of
by denaturing PAGE. In this way, we were able to map[32P]UTP 96-mer RNAs containing 52 bases of random
the 5 and 3 boundaries for FMRP binding to sc1 tosequence. FMRP was eluted with imidazole, and coeluting
nucleotides 23–57.RNAs were pooled, amplified by reverse transcription
While generating RNase T1-digested sc1 fragmentsPCR, and retranscribed for subsequent RNA selection.
as size standards in the boundary mapping experiment,Sequencing clones from the 9th round of selection
we noted that two domains in sc1 were protected fromrevealed only five different species of cDNA (Figure 1B,
RNase T1, even in 7 M urea at 50C (Figure 3A, brackets).sc1–5). Round eight contained one additional clone
The protected domain identified by 5 labeling can be(sc6). Examination of these six sequences revealed a
predicted to form a stable stem with the protected do-common sequence motif of DWGG-N(0-2)-DWGG-
main identified by 3 labeling (Figure 3B). The 5 and 3N(0-1)-DWGG-N(0-1)-DWGG (Figures 1B and 1C).
boundaries map near the middle of the stem, suggestingTo determine the binding affinity of FMRP for each of
that a minimal 5–6 nucleotide stem is necessary forthe RNA species, nitrocellulose filter binding assays
FMRP binding.were performed with [32P]UTP RNAs (Figure 2A). The
In order to confirm the boundary mapping results,RNA with the highest affinity for FMRP, sc1, had a Kd
truncated RNAs were tested for FMRP binding by filterof 10 nM (Figures 1C and 2A); this is within the range
binding assay (Figure 3C). These results demonstratedwherein which several RNA binding proteins bind in vivo
that a 5–6 nucleotide stem was sufficient for high-affinitytargets.
FMRP binding. In order to test the importance of theTo assess whether FMRP interacts directly with sc1,
we performed an electrophoretic mobility-shift assay. stem, mutants were generated in which the stem se-
FMRP RNA Ligands
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Figure 2. Characterization of the Interaction
between FMRP and RNAs Identified by Se-
lection
(A) Nitrocellulose filter binding assay to deter-
mine the affinity of FMRP for sc1–6.
(B) Electrophoretic mobility shift analysis of
the interaction between purified fusion pro-
teins (FP) and RNA in the presence or ab-
sence of antibody (Ab). FMRP was incubated
with [32P]UTP sc1 RNA (lane 3), sc1 RNA plus
mAb2160 (lane 4), or irrelevant anti-T7 mAb
(lane 5). FMRP-shifted sc1 is indicated by a
small arrow and FMRP-sc1-mAb is indicated
by a large arrowhead. Another KH domain
protein (Nova) failed to shift sc1 (lane 2). The
migration of free sc1 RNA (lane 1) and an
irrelevant 230 bp fragment of 28S RNA (rRNA;
lane 6) or rRNA plus FMRP (lane 7) are shown.
quence was scrambled or replaced with As, both of in sc1 folds into an intramolecular G quartet (Figure
5A). G quartets are nucleic acid structures in which fourwhich abrogated FMRP binding (Figure 3C).
A number of point mutations and internal deletions were guanine residues are arranged in a planar conformation
stabilized by Hoogsteen-type hydrogen bonds. Two togenerated in the conserved sequence motif, and the bind-
ing of these RNAs was tested by filter binding assay four G quartets can stack and are stabilized by potas-
sium and sodium but are unable to form in lithium (Wil-(Figure 4). RNA mutations that had the most severe ef-
fects on FMRP binding (greater than 100-fold reduction liamson et al., 1989). In order to test whether formation
of a G quartet is necessary for FMRP binding, we as-in affinity) resulted from changing or deleting the paired Gs
(G33-G34, G37-G38, G42-G43, and G47-G48). In addition, sayed sc1 binding in K and Li buffers. FMRP-sc1
binding was abrogated in Li buffer, while binding to amutating two As (A35-A36) to a pair of Cs resulted in a
severe decrease in FMRP binding; this mutation may control RNA, sc11, which binds the KH2 domain of
FMRP (data not shown), was unaffected by the substitu-have abrogated a sequence-specific interaction or al-
tered the RNA secondary structure (see below). Five tion of Li for K in the binding buffer (Figure 5B).
To further test whether sc1 folds into a G quartet,additional mutations outside of these paired Gs also
resulted in a marked decrease in FMRP affinity, including RNase T1 digestion was performed (Figures 5C and 5D).
Under the reaction conditions used, RNase T1 cleavesdeletion or mutation of A39 and mutation of G40-U41
to U40-A41. Mutations that had only minimal effects on RNA specifically on the 3 side of unpaired Gs. Each
of the paired Gs in sc1 was protected from RNase T1RNA binding affinity (less than 20-fold) included changing
G38 to an A, (discussed below), U49-U50 to A49-A50 (nu- digestion in K buffer relative to Li buffer, suggesting
that these nucleotides are base-paired in the G quartetcleotides that lie between the conserved bases and the
stem), and changing all 4 DWGG elements to GUGG. structure proposed. G31, G40, and G46 are protected
from cleavage in K buffer but are not predicted to takeThe presence of four sets of paired Gs crucial for FMRP
binding suggested a structure in which the loop present part in the G quartet. These bases may be base paired
Figure 3. Minimal RNA Sequence Bound by
FMRP
(A) Sc1 RNA, end-labeled with 32P on the 3
or 5 end, was subject to limited alkaline
hydrolysis (Alk hyd.), incubated with FMRP,
filtered over nitrocellulose to capture RNA-
protein complexes, and analyzed by autoradi-
ography. RNase T1-treated RNA generated
size standards. Brackets indicate domains pro-
tected from RNase T1 digestion. The 5 and
3 boundaries for the interaction between sc1
and FMRP are indicated by an asterisk.
(B) Stem loop predicted by RNase T1 protec-
tion and indication of the 5 and 3 boundaries
(arrows) of the stem.
(C) The indicated RNAs were assayed for
FMRP binding by filter binding;  indi-
cates binding with Kd equivalent to sc1, 
indicates no detectable binding.
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studies demonstrated that the RGG box alone had an
affinity of 10 nM for sc1 RNA, indistinguishable from the
affinity of full-length FMRP. Because RGG boxes have
been suggested to be nonspecific RNA binding do-
mains, RGG binding to a number of control RNAs was
assessed (Figure 6D). Mutation of the GG pair in either
the second or third DWGG elements decreased binding
to the RGG box by at least three orders of magnitude,
comparable to results obtained with full-length FMRP
(Figure 4). In addition, sc11, a 230 bp fragment of 28S
rRNA, and the starting pool of random 96-mer RNAs
from which sc1 was selected showed no significant RGG
box binding (data not shown). These results confirm that
the FMRP RGG box binds with high affinity to RNA in a
structure- and sequence-specific manner.
FMRP RNA Targets Predicted from RNA Selection
We next identified mRNA transcripts that might be
Figure 4. Mutational Analysis of sc1 RNA
bound by FMRP by searching UniGene for the G quartet
Mutations in truncated sc1 RNAs (bp 1–58) were assayed for FMRP consensus sequence surrounded by a 6 bp stem within
affinity by filter binding assay. Nucleotides involved in stem forma-
four nucleotides of the DWGG elements by using RNA-tion are indicated in purple, loop sequences are in black, mutations
Bob, a program capable of searching for both structural-are in red, unchanged bases are shown by a dash, and deletions
are shown as . Reductions in FMRP binding are indicated relative and sequence-specific elements (Eddy, 2001; Gautheret
to sc1. These results were duplicated with a smaller sc1 truncation et al., 1990). This search predicted 71 FMRP binding
(bp 13–58; data not shown). sites from 245,000 sets of human, rat, and mouse se-
quences in the UniGene databases. These 71 sequences
were folded by mfold version 3.1 (Mathews et al., 1999;
with other bases present in the 96-mer RNA in conven- Zuker et al., 1999), and those sequences which had
tional Watson-Crick interactions, or they may be steri- competing internal stems were discarded, leaving 31
cally hindered from digestion due the compact folding RNAs harboring candidate FMRP binding sites (0.01%
of the RNA and the relatively large size of RNase T1 of the UniGene database). Of these, 12 were assayed
(Ehresmann et al., 1987). In contrast to the loop se- for FMRP binding (Table 1); six bound to FMRP with
quence Gs proposed to base pair in a G quartet, the G affinities ranging from Kd 75 nM to 467 nM (Figure 7A
nucleotides present in the sc1 stem are protected from and Table 1) while six showed no appreciable binding.
digestion by base-pairing in both buffers. A control RNA, We also assessed FMRP binding to RNAs found to
sc11, is equally susceptible to RNase T1 in K or Li. be candidate targets in the accompanying paper by
To confirm these results, a time course of RNase T1 Brown et al. (2001) in this issue of Cell. We assessed
digestion was performed with sc1 in K versus Li buff- both FMRP binding to the RNA most enriched in FMRP
ers in an independent experiment. At all time points the IPs from brain (Sec-7-related transcript KIAA0763, a
paired Gs are protected from T1 digestion in K relative guanine nucleotide exchange factor [Sec-7 related
to Li. The Gs from 3 to G71 are cleaved equally well GEF]) and RNAs found both to coimmunoprecipitate
under both conditions (Figure 5D). The observation that with FMRP from brain and to be altered in their polysome
the mutation of G38 to A38 had little effect (Figure 4) is distribution in lymphoblastoid cell lines derived from
consistent with the observation that RNA G quartets fragile X patients (14 of the RNAs listed in Table 3 of
may be able to form using G-A Hoogsteen base pairs Brown et al., 2001). These RNAs were searched for
(Awang and Sen, 1993; Lee, 1990; Sundquist and Klug, FMRP binding sites by the use of the RNABob algorithm,
1989). Taken together, these results demonstrate that identifying 11 elements that were tested for direct FMRP
FMRP binds sc1 in a manner that is dependent on the interaction. Sec-7-related GEF mRNA bound FMRP with
RNA folding into a G quartet. an affinity of 322 nM; of 11 polysome-altered targets
tested, seven bound with affinity to FMRP ranging from
194 nm to 599 nM while four had undetectable bindingThe FMRP RGG Box Binds the sc1 G Quartet
In order to determine the domains of FMRP responsible (Figure 7A and Table 1).
To assess whether the RNAs listed in Table 1 boundfor binding to sc1, we generated the I304N mutation in
the KH2 domain and the equivalent mutation in the KH1 FMRP in a G quartet-dependent manner, we assessed
binding in the presence of Li versus K, and we gener-domain of full-length FMRP, both singly and in combina-
tion. These mutant proteins bound sc1 nearly as well ated mutants in which the paired Gs were changed to
Cs. In each case tested (ten targets assayed in the pres-as wild-type FMRP, suggesting that sc1 RNA binds
FMRP in a KH domain-independent manner (Figure 6A). ence of Li and six mutated RNA targets; see Table 1),
FMRP binding was abrogated (Figure 7B and data notTesting the isolated N and C termini of FMRP revealed
that all the sc1 binding activity is in the C-terminal do- shown). These results demonstrate that FMRP binds
with high affinity to G quartet elements in these tran-main of FMRP, distal to the KH domains (Figure 6B).
We made truncated constructs of the FMRP C termi- scripts and supports the utility of RNA selection in identi-
fying in vivo targets.nus to map the sc1 binding domain (Figure 6C). These
FMRP RNA Ligands
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Figure 5. sc1 RNA Forms an Intramolecular
G Quartet
(A) Schematic representation of the proposed
structure of sc1 RNA, showing proposed
Hoogsteen base-paired Gs and a stem. Nu-
cleotide numbers correspond to Figure 4.
(B) sc1 RNA or a control RNA (sc11) were
assayed for FMRP binding in buffer con-
taining K or Li.
(C) End-labeled sc1 or sc11 RNA was di-
gested with RNase T1 under native condi-
tions in either K- or Li-containing binding
buffer, as indicated. Gs proposed to be in-
volved in the Hoogsteen base pairs are indi-
cated by brackets. The position of every G is
indicated by bars.
(D) Time course in minutes (min) of sc1 RNA
digestion in K versus Li buffer.
Discussion transformer RNA bound by sex-lethal (Singh et al., 1995),
the U1 stem-loop RNA recognized by the U1snRNP-A
(U1-A) protein (Tsai et al., 1991), and HIV-1 Rev-respon-RNA Selection to Identify In Vivo FMRP
mRNA Targets sive element recognized by the Rev protein (Bartel et
al., 1991).Despite the recognition that FMRP is an RNA binding
protein, the inability to identify in vivo RNAs upon which In a few instances, most notably in studies of two
families of neuronal RNA binding proteins targeted inFMRP acts has left a critical gap in our understanding
of how its absence leads to mental retardation. FMRP neurologic syndromes termed paraneoplastic neuronal
degenerations (PNDs), RNA selection has allowed iden-has been reported to bind to a subset of total cellular
RNAs; however, there has been little progress in under- tification of biologically relevant RNA targets. Keene and
colleagues used RNA selection to identify AU-rich RNAstanding the structural or sequence specificities of
FMRP’s RNA binding domains or in using such data to elements as targets of the Hu PND antigens (Levine et
al., 1993), a family of RRM-type RNA binding proteinsassess the action of FMRP on RNA targets in vivo.
We have approached this problem by combining in subsequently documented to play important roles in
mediating RNA stability and translational control throughvitro RNA selection methods together with biologic stud-
ies. RNA selection methods (Ellington and Szostak, binding to 3 UTR elements (Fan and Steitz, 1998; Jain
et al., 1997; Keene, 1999). Nova protein, a KH-type RNA1990; Tuerk and Gold, 1990) have been used to demon-
strate that RNA binding proteins with known target RNAs binding protein, was used in RNA selection experiments
to identify UCAU-rich RNA targets, confirmed by X-raywere able to select those RNA sequences from random
pools of RNAs, including the polypyrimidine tract of crystallography (Buckanovich and Darnell, 1997; Jensen
Cell
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Figure 6. Domain Mapping and Specificity of
the FMRP-RNA Interaction
(A) Binding of full-length wild-type or KH do-
main mutant FMRP to sc1 RNA. Mutations
are the I304N mutation in KH2, the analogous
mutation in KH1, or both (KH1  KH2).
(B) sc1 binding to FMRP N and C termini fu-
sion proteins (see Experimental Procedures).
(C) The FMRP C terminus assayed in (B) is
shown, together with diagrams of truncated
proteins, which were assessed for sc1 bind-
ing ( indicates binding equivalent to the full-
length C terminus;  indicates no detectable
binding). The Rev-like nuclear export signal
and the RGG box are indicated.
(D) Binding specificity of the RGG box (cterm
10) to truncated sc1 RNAs (bp 1–58), or mu-
tants G37-G38 or G42-G43 to CC. The RGG
box also showed no binding to sc11 or rRNA
(data not shown).
et al., 2000b; Lewis et al., 2000; Yang et al., 1998). Nova nucleotide bases and unfolds RNA secondary structure,
thereby allowing sequence-specific RNA binding do-binds an intronic UCAU-rich element to regulate splicing
of the inhibitory glycine receptor pre-mRNA, findings mains to access their targets (Ghisolfi et al., 1992a).
However, the RGG box of hnRNP U can apparently dis-confirmed in Nova-1 null mice (Buckanovich and Darnell,
1997; Grabowski, 2000; Jensen et al., 2000a; Polydo- criminate between sequences (Kiledjian and Dreyfuss,
1992). The current results clearly demonstrate that RGGrides et al., 2000).
We have now used RNA selection to strictly define the domains are capable of specific RNA target recognition.
Recognition of RNA by the FMRP RGG box appearsRNA elements required for high-affinity FMRP binding.
This, in turn, allowed us to develop stringent screening to have both a structural component—binding to a G
quartet presented in the context of a stem—and a se-criterion to identify candidate FMRP mRNA targets; 31
candidate mRNAs were identified from the UniGene da- quence-specific component, since mutagenesis of sc1
nucleotides not involved in either the G quartet or in thetabase (0.01%). To assess the in vivo relevance of these
mRNAs, their polysome distribution was compared in stem are able to markedly reduce FMRP binding (Figure
4). Specifically, five different mutations outside of thecells of fragile X syndrome patients and in those of
normal individuals, as described in the accompanying GG repeats were able to significantly abrogate binding.
paper by Brown et al. (2001). Two of the four candidate Moreover, the RNA selection consensus itself suggests
mRNAs showed altered polysome distributions, provid- sequence specificity in the loops; for example, a U or
ing validation of the ability of this in vitro approach to an A almost always precedes the GG pairs. The simplest
identify physiologically relevant mRNA targets. interpretation of this data is that FMRP has sequence
In addition, we assessed 14 mRNAs identified inde- preference for the loops surrounding the G quartet el-
pendently by Brown et al. (2001) as having altered poly- ement.
some distributions, and found nearly half (six) harbored G quartet elements have been described in a number
high-affinity G quartet FMRP binding sites, demonstra- of forms. They can be intramolecular structures, al-
ting the utility of combining these approaches. though they have more commonly been reported as
bimolecular or tetramolecular structures. It is likely that
the structure of the sc1 RNA is an intramolecular GThe FMRP RGG Box Is a Sequence-Specific RNA
quartet as opposed to a two- or four-stranded interac-Binding Element
tion. On native gels, only a single sc1 RNA species isAlthough the existence of the disease-associated I304N
present, and it comigrates with a control 96-mer thatFMRP mutation has appropriately drawn attention to
does not form a G quartet structure (sc11, data notRNAs that bind to the KH domains, we unexpectedly
shown). We have never observed a band of the expectedfound that the RGG box acts as a sequence-specific
size of a dimer or tetramer. Moreover, the rapid rate atRNA binding domain in FMRP. Previous data has sug-
which these form in very dilute RNA solutions (within 10gested that RGG domains act as nonspecific RNA bind-
min after 75C denaturation at 1.8 nM RNA) suggestsing domains. In nucleolin, specific RNA binding requires
that FMRP binds an intramolecular G quartet structure.its four RRMs, but the presence of an RGG box increases
G quartet elements serve as physiologic targets ofits affinity for its targets 10-fold (Ghisolfi et al., 1992b). It
has been proposed that the RGG box unstacks adjacent several nucleotide binding proteins. They were first de-
FMRP RNA Ligands
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Table 1. FMRP RNA Targets
Kd Location Alteration in GenBank
mRNA (nM) of Target G Quartet ID Fra(X) Polysomes Accession Code
Semaphorin 3F, human 75 3 UTR Yes UniGene Decreased NM_004186
GGGGGGTGATTGGAAGGGAGGGAGGTG
Potassium Channel Kv3.1, rat 113 5 UTR Yes UniGene Unchanged NM_012856
TGGCTCGTTGGTTGGGGTGGGTGGCCA
Arginine vasopressin receptor, V1a, mouse 156 3 UTR Yes UniGene Decreased D49730
GTTGGGTTGAGGGTGGGAAGGAAGGTAG
Srm tyrosine kinase, human 171 Coding Yes UniGene N.D. AL121829
GGCTACTTTGGGGAGGTGTGGGAAGGCCT
Histone H4, mouse 190 Coding Yes UniGene N.D. V00753
TGTCTGGCAGAGGAAAGGGTGGAAAGGGT
Transcription differentiation inhibitor, ID3, human 467 3 UTR Yes UniGene Unchanged NM_002167
AGAGCGTGGAGGTGTGGAAGGAGTGGCTGCTCT
Guanine nucleotide exchange factor, human 322 3 UTR Yes Co-IP N.D. NM_014869
GGGGAGGCAGGAGGAGGCCGAGG
MAP1B, transcript 1, human 505 5 UTR Yes Polysome & Co-IP Increased NM_005909
TCGCGGCGCTGGGAGAGGGCGGAGGGGGAGGCGG
Msx2-interacting nuclear protein (Mint), mouse 462 Coding Yes Polysome & Co-IP Increased NM_019763
GACGAGCGCAGGGAGGAGGAGCAGGAGAGGCAG
GT334/TMEM1/EHOC-1, site 1, human 505 3 UTR Yes Polysome & Co-IP Increased U61500
CCCTTCTAGGGGAGGCGGGTGGGGGAG
GT334/TMEM1/EHOC-1, site 2, human 425 3 UTR N.D. Polysome & Co-IP Increased U61500
TGTGCTTGCGGGAGGCGGTGGGGCATGGGAGGAAG
Munc13, mammalian homolog of unc13, human 194 3 UTR N.D. Polysome & Co-IP Decreased AF020202
CCCTGGCCCAACAGGACTGTGGTACTAGGGGCTGGG
Neuronal acidic membrane protein, NAP-22, human 599 Coding N.D. Polysome & Co-IP Decreased AI214799
CGCCTAGGGCAAGGCCGAGGAGAAGG
Rab6 interacting protein, KIAA 1091, mouse 275 Coding N.D. Polysome & Co-IP Decreased AJ245569
TCCGTGTGGCCGATGGCTGGGGAAGGG
RNA targets were identified through RNABob searching (UniGene), in vivo co-IP/gene-chip analysis (Co-IP), or through analysis of targets
altered in their polysome distribution in fragile X patient cells (Polysome/IP). Kds were determined by filter binding assay, using both full-
length FMRP and the C-terminal RGG box. G quartet-dependent binding was assessed by measuring Li sensitive FMRP binding (the first
ten RNAs listed) and by mutation of Hoogsteen-paired Gs (the first six RNAs listed). Of 11 Polysome/IP targets tested, four did not bind FMRP
and are not listed. UniGene was searched with S6-N(0–3)DWGG-N(0–1)DWGG-N(0–1)DWGG-N(0–1)DWGG-N(0–3)-S6(S  stem) and polysome/
IP targets using (S5-N(0–7)WGG-N(1–4)WGG-N(1–4)WGG-N(1–4)WGG-N(0–6)-S5. N.D.  not determined.
scribed in protozoan telomeric DNA (Sen and Gilbert, volved in genetic recombination (Fry and Loeb, 1999;
Sun et al., 1998), and nucleolin and hnRNP D form LR1,1988; Sundquist and Klug, 1989; Williamson et al., 1989)
and were subsequently described as targets of several a complex that binds G quartets involved in IgG heavy
chain class switch recombination (Dempsey et al., 1999).telomeric DNA binding proteins, including yeast protein
RAP1 (Giraldo and Rhodes, 1994; Williamson, 1994), the Perhaps the best example of a physiologically relevant
RNA G quartet is in the filamentous bacteriophage fd, subunit of Oxytricha telomere binding protein (Fang
and Cech, 1993), and tel2p (Kota and Runge, 1999). where translation of the gene 2 product is repressed by
the binding of a protein factor, g5p, to a G quartet inMore recently, BLM and WRN (helicases mutated in
Bloom’s and Werner’s syndromes, respectively) have the leader sequence of its mRNA. Mutations in this se-
quence that inhibit G quartet formation abrogate g5pbeen found to bind DNA G quartets thought to be in-
Figure 7. FMRP Binding to Candidate
mRNAs
(A) RNAs identified by searching Unigene
(ID3, srm kinase) or a database of mRNAs
with altered polysome distribution in fragile
X patient cells (accompanying paper, Brown
et al., Table 3) were screened to identify
FMRP binding targets. Twenty-four RNA frag-
ments (see Table 1 and text) were assayed for
binding to full-length FMRP; 6 representative
curves are shown.
(B) The binding of the mouse guanine nucleo-
tide exchange factor (Sec-7-related GEF)
RNA was assayed for FMRP binding in K
(circles), Li (triangles), and an anti-sense ver-
sion of the transcript was assayed in K
(squares). These results were duplicated us-
ing the C terminus of FMRP (data not shown).
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binding and correlate with in vivo mutations that alter ID3 is expressed in the proliferative zone of the hippo-
campus that gives rise to granule cells and dentate pre-the translational repression of gene 2 mRNA (Oliver et al.,
2000). This mechanism is reminiscent of the proposed cursor cells (Pleasure et al., 2000).
Several other candidate mRNA targets are also offunction of FMRP in translational regulation and sug-
gests a scenario in which FMRP might analogously rec- interest with respect to fragile X mental retardation.
MINT is a double-stranded DNA binding protein ex-ognize G quartets in the untranslated regions of mRNAs
to inhibit their translation. pressed at high levels in testes and at lower levels in
brain and calvarial osteoblasts. In the latter cell type, it
binds the osteocalcin promoter and its transcriptionalFMRP-Target RNAs Encode Proteins Involved
activity is regulated by the homeodomain transcriptionalin Neuronal Development and Synaptic Function
repressor msx2, which exerts tissue-specific effectsRemarkably, almost all of the 13 mRNAs identified by our
during craniofacial and neural development (Newberrystrategy (Table 1) have biologic functions of relevance to
et al., 1999). Srm kinase is a novel nonreceptor tyrosinethe fragile X syndrome. As a group, the RNAs identified
kinase encoded by two transcripts, one of which isencode proteins with roles in maintaining proper synap-
brain- and testes-specific (Kohmura et al., 1998). Littletic function, mediating neuronal development, or in cra-
is known about the function of the protein encoded byniofacial development.
the EHOC-1 gene. It was cloned as a candidate geneSix mRNAs harboring FMRP target elements are asso-
for myoclonus epilepsy and has multiple potential trans-ciated with synaptic function. The FMRP binding site
membrane domains and partial homologies to sodiumcharacterized in human munc13 corresponds to the rat
channel proteins (Yamakawa et al., 1995).isoform munc13-2, which is present in the rostral brain
regions including the cerebral cortex and CA regions of
the hippocampus (Augustin et al., 1999). Munc proteins Conclusion
have essential functions in synaptic vesicle priming in The finding that many of the mRNA targets identified
the active zone of the synapse (Augustin et al., 1999, are involved in either synaptic function or dendritic
2001; Brose et al., 2000). NAP-22 is a Ca2-dependent growth fits extremely well with several previous observa-
calmodulin binding protein present in axon terminals tions regarding the role of FMRP in mental retardation.
and dendritic spines (Iino et al., 1999) that localizes to A growing body of literature suggests that activity-
the membrane raft domain (Maekawa et al., 1999) and dependent local translation may be important in synap-
is likely to play an important role in the maturation or tic plasticity (Aakalu et al., 2001; Steward and Schuman,
maintenance of synapses (Maekawa et al., 1999). V1a 2001). A plausible model is that FMRP binds specific
is a G protein-coupled arginine vasopressin receptor RNA elements, either regulating the translation of RNAs
(Barberis and Tribollet, 1996). Vasopressin causes a important for synaptic function or the targeting of certain
long-lasting facilitation of glutamate-mediated excita- mRNAs to the dendrite, where they await signaling that
tion in the septum-hippocampus complex and is thought would allow translation. The ability to functionally tie
to facilitate learning and memory (Urban, 1998). In addi- together the disorder, the FMR protein, and the set of
tion, the V1a receptor is strongly implicated in the regu- mRNA targets makes a compelling argument that the
lation of social behaviors and aggression (Young et al., failure of FMRP to regulate these mRNAs plays a key role
1999). Kv3.1 is a subunit of a tetrameric voltage-gated in the pathogenesis of the fragile X mental retardation
K channel of the Drosophila Shaw-like subfamily. syndrome.
These channels are important in facilitating sustained
or repetitive high-frequency firing of the GABAergic in-
Experimental Proceduresterneurons of the neocortex and hippocampus (Lau et
al., 2000; Young et al., 1999). Sec-7-related GEF belongs FMRP Fusion Proteins
to a family of mammalian Sec7-like proteins that function PCR amplification of a human fetal cDNA library was used to clone
the iso7 form of FMRP. Cloning into pET21b (Novagen, Madison,as guanine-nucleotide exchange factors, signaling
WI) yielded an N-terminally T7-tagged and C-terminally histidine-through IP3 receptors and PI3-kinase, and are involved
tagged FMRP fusion protein. The pMelBac system (InVitrogen, Sanin vesicle transport and other activities in neurons (Jack-
Diego, CA) was used to express secreted FMRP.son and Casanova, 2000). Rab6 binding protein binds
KH1 and KH2 domain isoleucine to asparagine mutations were
rab6 (Janoueix-Lerosey et al., 1995), a Golgi-localized introduced into pMelBacBFMR1 by PCR. Individual domains of
GTPase which plays an important role in intracellular FMRP were cloned by PCR amplification with pMelBacBFMR1 as
a template and were ligated into pET21b to produce N-terminallyvesicle trafficking (Martinez and Goud, 1998), including
T7-tagged and C-terminally histidine-tagged fusion proteins. Thea dendritic spine secretory pathway (Pierce et al., 2001).
boundaries of the domains refer to the GenBank accession numberThree mRNA targets encode proteins involved in neu-
XM_010288 for human FMR1 mRNA. The N terminus ends at nucleo-ritic extension and neuronal development. MAP1B is
tide (nt) 764 and the C terminus begins with nt 1329. cterm 10
highly expressed in developing neurons and appears to includes nt 1634–1729. Baculoviral fusion proteins were produced in
play an important role in the extension of axons and High Five cells according to manufacturer’s instructions (Invitrogen)
and purified according to the pET system manual (Novagen) bydendrites by regulating microtubule stability and organi-
using IMAC-0 (20 mM HEPES [pH 8.4] and 1 M KCl) as equilibrationzation (Mandell and Banker, 1996; Takei et al., 2000).
buffer, then washing with IMAC-0 plus 30 mM imidazole and elutingSemaphorin 3F is a secreted neuronal protein that has
with 200 mM imidazole in IMAC-0. FMRP was dialyzed againstinhibitory and stimulatory effects on growth cones and
PBS  5 mM MgCl2. The protein was then purified on a polyguanylicis essential for axon pathfinding (Giger et al., 1998). ID3 acid column (Sigma Chemical, St. Louis, MO, riboG) preequilibrated
binds to basic helix-loop-helix transcription factors to with riboG binding buffer (10 mM Tris-HCl [pH 7.4], 2.5 mM MgCl2,
and 150 mM NaCl). Following washes in 250 mM NaCl, the proteinform an inactive dimer, thereby inhibiting differentiation.
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was eluted with 1 M NaCl. Purified FMRP was assessed for purity Abitbol, M., Menini, C., Delezoide, A., Rhyner, T., Vekemans, M.,
and Mallet, J. (1993). Nucleus basalis magnocellularis and hippo-by colloidal gold (BioRad) or amido black 10B (Sigma) staining.
Bacterial fusion proteins were expressed and purified according campus are the major sites of FMR-1 expression in the human fetal
brain. Nature Genet. 4, 147–153.to the pET system manual (Novagen).
Absher, D., Fridovich-Keil, J., and Warren, S.T. (2001). The impor-
In Vitro RNA Selection tance of the KH-domain for dimerization and polyribosome associa-
RNA selection, transcription, and gel purification were carried out tion revealed in a yeast model of FMRP function.
as described (Buckanovich and Darnell, 1997), with the following Ashley, C.T., Wilkinson, K.D., Reines, D., and Warren, S.T. (1993).
modifications. The buffer used for the application of RNA to the FMR-1 protein: conserved RNP family domains and selective RNA
FMRP column was selection binding buffer (SBB, 200 mM KOAc, binding. Science 262, 563–566.
10 mM TrisOAc [pH 7.7], and 5 mM MgOAc), and the protein RNA
Augustin, I., Betz, A., Herrmann, C., Jo, T., and Brose, N. (1999).complexes were eluted with SBB  200 mM imidazole. RNA was
Differential expression of two novel Munc13 proteins in rat brain.reverse transcribed with Superscript (GIBCO-BRL, Life Technolo-
Biochem. J. 337, 363–371.gies) and PCR amplified with selection primers (Buckanovich and
Augustin, I., Korte, S., Rickmann, M., Kretzschmar, H.A., Sudhof,Darnell, 1997). RNA transcription reactions included 0.4 mM NTPs
T.C., Herms, J.W., and Brose, N. (2001). The cerebellum-specificand 40 Ci [	-32P]UTP in 25 l reactions.
Munc13 isoform Munc13-3 regulates cerebellar synaptic transmis-
sion and motor learning in mice. J. Neurosci. 21, 10–17.Nitrocellulose Filter Binding Assays
Labeled RNA (100–200 nmol preheated to 75C and bench-cooled Awang, G., and Sen, D. (1993). Mode of dimerization of HIV-1 geno-
5 min) was incubated with the indicated concentrations of protein mic RNA. Biochemistry 32, 11453–11457.
that had been dialyzed into SBB. Protein-RNA mixes were incubated Barberis, C., and Tribollet, E. (1996). Vasopressin and oxytocin re-
in a total volume of 50 L SBB for 10 min at room temperature. ceptors in the central nervous system. Crit. Rev. Neurobiol. 10,
Binding solutions were passed through MF-membrane filters (0.45 119–154.
HA, Millipore) and washed with 5 ml SBB. Data were plotted as percent-
Bartel, D.P., Zapp, M.L., Green, M.R., and Szostak, J.W. (1991).age of total RNA bound versus log of the protein concentration, and Kds
HIV-1 Rev regulation involves recognition of non-Watson-Crick basewere determined with Kaleidograph software (Synergy Software).
pairs in viral RNA. Cell 67, 529–536.Where indicated, LiOAc was substituted for KOAc in the SBB.
Berglund, J.A., Abovich, N., and Rosbash, M. (1998). A cooperative
interaction between U2AF65 and mBBP/SF1 facilitates branchpointElectrophoretic Mobility Shift Assay
region recognition. Genes Dev. 12, 858–867.Native gel electrophoresis was performed as described (Jensen et
al., 2000a), with the following modifications. RNA was resuspended Brose, N., Rosenmund, C., and Rettig, J. (2000). Regulation of trans-
in RNA dilution buffer (100 mM KOAc, 50 mM TrisOAc [pH 7.7], and mitter release by Unc-13 and its homologues. Curr. Opin. Neurobiol.
5 mM MgOAc) and incubated with protein at a concentration of 100 10, 303–311.
nM. Where indicated, 1 l of monoclonal antibodies (anti-FMRP is Brown, V., Jin, P., Ceman, S., Darnell, J.C., O’Donnell, W.T., Tenen-
Mab2160, Chemicon, anti-T7 from Novagen) were mixed with the baum, S.A., Jin, X., Wilkinson, K.D., Keene, J.D., Darnell, R.B., and
proteins before the addition of RNA. Warren, S.T. (2001). Microarray identification of FMRP-associated
brain mRNAs and altered mRNA translational profiles in fragile X
Boundary Mapping syndrome. Cell 107, this issue, 477–487.
Boundary mapping was performed as described (Fitzwater and Po-
Buckanovich, R.J., and Darnell, R.B. (1997). The neuronal RNA bind-lisky, 1996), with the following modifications. In vitro-transcribed
ing protein Nova-1 recognizes specific RNA targets in vitro and insc1 RNA (60 pmol) was 3 end-labeled with T4 RNA ligase (New
vivo. Mol. Cell. Biol. 17, 3194–3201.England Biolabs) and [32P]pCp (Amersham). Sc1 RNA (40 pmol) was
Burd, C.G., and Dreyfuss, G. (1994). Conserved structures and diver-5 end-labeled with T4 polynucleotide kinase (New England Biolabs)
sity of functions of RNA-binding proteins. Science 265, 615–621.and [
-32P]ATP. Following gel purification, RNA was digested with
2l RNase T1 (GIBCO-BRL, 1180 units/l). Following alkaline hydro- Comery, T.A., Harris, J.B., Willems, P.J., Oostra, B.A., Irwin, S.A.,
lysis, RNA was resuspended in 20 l DEPC H2O and used in filter Weiler, I.J., and Greenough, W.T. (1997). Abnormal dendritic spines
binding assays with or without 100 nM FMRP. in fragile X knockout mice: maturation and pruning deficits. Proc.
Natl. Acad. Sci. USA 94, 5401–5404.
RNase T1 Digestion DeBoulle, K., Verkerk, A., Reyniers, E., Vits, L., Hendrickx, J., Van
5 end-labeled RNA was digested with 0.2 units RNase T1 in 100 l Roy, B., Van Den Bos, F., de Graaff, E., Oostra, B., and Willems, P.
aliquots of 150 mM KCl or LiCl, 100 mM Tris-HCl (pH 7) for 5 min (1993). A point mutation in the FMR-1 gene associated with fragile
at 37C or the time indicated. For the time course, 10l aliquots were X mental retardation. Nature Genet. 3, 31–35.
removed at the indicated times and stopped with 6 l formamide-
Dempsey, L.A., Sun, H., Hanakahi, L.A., and Maizels, N. (1999). G4loading buffer.
DNA binding by LR1 and its subunits, nucleolin and hnRNP D, A
role for G-G pairing in immunoglobulin switch recombination. J. Biol.
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